Rosen Law Firm Urges Sage Therapeutics, Inc. (NASDAQ: SAGE) Shareholders Experiencing Large Losses to Contact the Firm for Information About Their Rights

Rosen Law Firm, a global investor rights law firm, announces that a shareholder has filed a class action lawsuit on behalf of all purchasers of Sage Therapeutics, Inc. (NASDAQ: SAGE) securities between April 12, 2021 and July 23, 2024. Sage describes itself as a “biopharmaceutical company developing and commercializing medicines for brain health.”

For more information, please complete a form, email attorney Phillip Kim, or call us at 866-767-3653.